AAPL348.22+4.23 (+1.23%) ▲|ABBV285.19+0.39 (+0.14%) ▲|ABT102.51+2.00 (+1.99%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|AAPL348.22+4.23 (+1.23%) ▲|ABBV285.19+0.39 (+0.14%) ▲|ABT102.51+2.00 (+1.99%) ▲|ACN258.74+18.48 (+7.69%) ▲|ADBE270.55+15.49 (+6.07%) ▲|AMAT375.58-33.36 (-8.16%) ▼|AMD507.93-44.79 (-8.10%) ▼|AMGN447.28+8.94 (+2.04%) ▲|AMT181.60+3.96 (+2.23%) ▲|AMZN250.38-11.99 (-4.57%) ▼|AVGO323.24-14.56 (-4.31%) ▼|AXP325.07+1.46 (+0.45%) ▲|BA187.53-4.75 (-2.47%) ▼|BAC51.10+0.32 (+0.63%) ▲|BKNG161.10+2.72 (+1.72%) ▲|BLK1,137.54-12.06 (-1.05%) ▼|BMY63.01+1.89 (+3.09%) ▲|BNY145.32-0.53 (-0.36%) ▼|BRK-B547.00+8.01 (+1.49%) ▲|C122.56-1.29 (-1.04%) ▼|CAT703.84-36.38 (-4.91%) ▼|CL97.40+4.00 (+4.28%) ▲|CMCSA22.84+0.76 (+3.44%) ▲|COF203.44-3.22 (-1.56%) ▼|COP145.64-0.03 (-0.02%) ▼|COST1,018.21+19.90 (+1.99%) ▲|CRM250.24+8.46 (+3.50%) ▲|CSCO104.89-2.37 (-2.21%) ▼|CVS94.49+1.71 (+1.84%) ▲|CVX226.65-0.13 (-0.06%) ▼|DE643.60+7.06 (+1.11%) ▲|DHR229.88-3.98 (-1.70%) ▼|DIS113.14+1.31 (+1.17%) ▲|DUK125.42+4.75 (+3.94%) ▲|EMR160.26-2.85 (-1.75%) ▼|FDX303.99+5.76 (+1.93%) ▲|GD350.76+6.05 (+1.75%) ▲|GE293.51-2.37 (-0.80%) ▼|GEV827.38-98.55 (-10.64%) ▼|GILD157.19+3.62 (+2.36%) ▲|GM77.22+1.11 (+1.46%) ▲|GOOG320.76-10.19 (-3.08%) ▼|GOOGL324.22-10.54 (-3.15%) ▼|GS891.27-13.45 (-1.49%) ▼|HD327.66+13.52 (+4.30%) ▲|HON218.31+3.58 (+1.67%) ▲|IBM252.19+0.73 (+0.29%) ▲|INTC85.49-7.47 (-8.04%) ▼|INTU354.90+19.29 (+5.75%) ▲|ISRG443.85+15.73 (+3.67%) ▲|JNJ267.68+9.90 (+3.84%) ▲|JPM336.51+1.32 (+0.39%) ▲|KO95.34+2.66 (+2.87%) ▲|LIN510.36+9.79 (+1.96%) ▲|LLY1,306.74+35.99 (+2.83%) ▲|LMT590.20+38.69 (+7.01%) ▲|LOW204.39+7.83 (+3.98%) ▲|LRCX230.15-30.66 (-11.76%) ▼|MA632.81+10.19 (+1.64%) ▲|MCD252.55+6.30 (+2.56%) ▲|MDLZ65.19+2.45 (+3.91%) ▲|MDT96.58+3.55 (+3.82%) ▲|META648.85-48.67 (-6.98%) ▼|MMM175.54+0.80 (+0.46%) ▲|MO76.07+2.24 (+3.03%) ▲|MRK147.25-2.63 (-1.75%) ▼|MS183.94-3.08 (-1.64%) ▼|MSFT521.08-11.87 (-2.23%) ▼|MU856.49-57.18 (-6.26%) ▼|NEE81.91+3.63 (+4.64%) ▲|NFLX67.05+2.01 (+3.09%) ▲|NKE38.31+0.78 (+2.08%) ▲|NOW157.00+3.88 (+2.53%) ▲|NVDA212.21-9.76 (-4.40%) ▼|ORCL125.52-3.62 (-2.80%) ▼|PEP138.83+4.13 (+3.07%) ▲|PFE30.41+0.56 (+1.88%) ▲|PG165.60+8.76 (+5.59%) ▲|PLTR196.19-5.53 (-2.74%) ▼|PM201.76+4.30 (+2.18%) ▲|QCOM172.83-5.13 (-2.88%) ▼|RTX194.71+3.11 (+1.62%) ▲|SBUX101.91+2.83 (+2.86%) ▲|SCHW91.44-0.20 (-0.22%) ▼|SO93.82+3.43 (+3.79%) ▲|SPG212.04+6.49 (+3.16%) ▲|T22.74+0.83 (+3.79%) ▲|TMO676.55-17.47 (-2.52%) ▼|TMUS158.79+5.04 (+3.28%) ▲|TSLA374.58-11.89 (-3.08%) ▼|TXN279.50-5.15 (-1.81%) ▼|UBER69.07+1.45 (+2.14%) ▲|UNH424.98+7.98 (+1.91%) ▲|UNP298.09+10.22 (+3.55%) ▲|UPS101.52+1.95 (+1.96%) ▲|USB60.02+0.97 (+1.64%) ▲|V414.34+6.49 (+1.59%) ▲|VZ45.20+1.64 (+3.76%) ▲|WFC83.01+0.59 (+0.72%) ▲|WMT121.12+3.32 (+2.82%) ▲|XOM178.23+0.14 (+0.08%) ▲|
19 C
New York
Thursday, October 22, 2026

Tag: pharmaceuticals

MSG Rangers and Huron Consulting Group Set to Join S&P SmallCap 600

NEW YORK, Oct. 22, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P SmallCap 600:  MSG Rangers Inc. (NYSE:...

Quantinuum to Report Third Quarter Financial Results on November 5, 2026

BROOMFIELD, Colo., Oct. 23, 2026 /PRNewswire/ -- Quantinuum Inc. (NASDAQ: QNT) ("Quantinuum") today announced it will release its financial results for the third quarter...

Phylo’s Biomni Lab to expand the use of AI agents in scientific research at Bayer

SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 /PRNewswire/ -- Phylo, Inc. announced today a partnership with Bayer to deploy Biomni Lab, Phylo's agentic AI...

Vanda Pharmaceuticals to Announce Third Quarter 2026 Financial Results on October 28, 2026

Conference Call and Webcast to FollowWASHINGTON, Oct. 21, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for...

Microencapsulation Market worth $24.02 billion in 2031- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 21, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the microencapsulation market is projected to grow from USD 16.90 billion in 2026 to...

Chen Qiyu: Building on “Affordability & Reliability”, Fosun Expands the Global Reach of Chinese Innovative Drugs

HONG KONG, Oct. 21, 2026 /PRNewswire/ -- On 20 October, the Sustainability Global Leaders Conference 2026 was held in Shanghai. The Conference, themed "Building a...

Telix Reports Third Quarter 2026 Financial Performance

MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") provides a financial update on its commercial...

INOVIO Announces Favorable Judgment in Litigation with VGXI, Inc. and GeneOne Life Science

PLYMOUTH MEETING, Pa., Oct. 20, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to...

Lipid Nanoparticles Market worth $395.0 million by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 20, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Lipid Nanoparticles Market is projected to reach USD 395.0 million by 2031, up...

Lipid Nanoparticles Market worth $395.0 million by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 20, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Lipid Nanoparticles Market is projected to reach USD 395.0 million by 2031, up...

Condor Unveils AI-Powered Investigator Grants Intelligence

Condor uses AI to reconcile CRO and site-payment vendor data against trial activity and contracted rates, uncovering site performance patterns, assessing costs relative to...

Eloxx Pharmaceuticals Finalizes 52-Week Phase 2 EXPRESS Study Design in Nonsense-Mutation ADPKD and Appoints T.R. Srinivas, M.D., Chief Medical Officer

EXPRESS Phase 2 design finalized: 52 weeks of dosing of approximately 60 patients randomized 1:1 to exaluren or placebo, with annualized htTKV growth as...

Insmed Appoints Two New Directors to Its Board

—Paul Hudson, Former CEO of Sanofi and Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health and Veteran Biopharma Finance Leader, Join as New...

Telix and Ekalia to Collaborate on Astatine-211 Production in the U.S.

Collaboration establishes a framework for a dedicated U.S. source of astatine-211 (211At), a scarce, next-generation alpha-emitting isotope with significant potential in targeted alpha therapy...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPharmaceuticals